Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Immunotech Biopharm Ltd ( (HK:6978) ) has shared an update.
Immunotech Biopharm Ltd announced the resignation of Dr. Wang Yu from her roles as executive director, CEO, and CTO, effective June 25, 2025, due to disagreements with the board over governance issues. The board has appointed Mr. Zhang Jian as acting CEO and is actively seeking suitable candidates to fill the vacant positions, maintaining that the company’s operations remain unchanged.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, focusing on biopharmaceuticals. The company, along with its subsidiaries, operates in the biotechnology industry, primarily offering innovative medical solutions.
Average Trading Volume: 556,186
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.56B
Learn more about 6978 stock on TipRanks’ Stock Analysis page.